4-pyridyl-1,3-dioxane derivatives
    1.
    发明授权
    4-pyridyl-1,3-dioxane derivatives 失效
    4-吡啶基-1,3-二恶烷衍生物

    公开(公告)号:US5401849A

    公开(公告)日:1995-03-28

    申请号:US78658

    申请日:1993-06-21

    IPC分类号: C07D405/04 C07D405/14

    CPC分类号: C07D405/04 C07D405/14

    摘要: The invention concerns pharmaceutically useful 1,3-dioxane alkenoic acid derivatives of formula VII and formula XI containing a pyridyl moiety at position 4 of the dioxane ring and in which the groups at positions 2, 4 and 5 have cis-relative stereochemistry, wherein X is hydrogen, alkoxy or hydroxy, Y is vinylene, n is 1 or 2, A.sup.1 is alkylene, R.sup.1 is a variety of substituents defined hereinafter, Ra and Rb are independently methyl or ethyl, R.sup.2 is hydroxy, a physiologically acceptable alcohol residue or alkanesulphonamido, and the pharmaceutically acceptable salts thereof.

    摘要翻译: 本发明涉及式VII和式XI的药学上有用的1,3-二恶烷烯酸衍生物,其在二恶烷环的4位含有吡啶基部分,其中2,4和5位的基团具有顺式相对立体化学,其中X 是氢,烷氧基或羟基,Y是亚乙烯基,n是1或2,A1是亚烷基,R1是下文定义的各种取代基,R a和R b独立地是甲基或乙基,R 2是羟基,生理上可接受的醇残基或烷基磺酰胺 ,及其药学上可接受的盐。

    Pyridyl substituted alkenoic acid derivatives
    4.
    发明授权
    Pyridyl substituted alkenoic acid derivatives 失效
    吡啶基取代的烯酸衍生物

    公开(公告)号:US5248780A

    公开(公告)日:1993-09-28

    申请号:US951760

    申请日:1992-09-25

    IPC分类号: C07D405/04 C07D405/14

    CPC分类号: C07D405/04 C07D405/14

    摘要: The invention concerns novel, pharmaceutically useful 1,3-dioxane alkenoic acid derivatives of the formula I containing a pyridyl moiety at position 4 of the dioxane ring and in which the groups at positions 2, 4 and 5 have cis-relative stereochemistry, X is hydrogen, alkoxy or hydroxy, Y is vinylene, n is 1 or 2, A.sup.1 is alkylene, R.sup.1 is a variety of substituents defined hereinafter, and R.sup.2 is hydroxy, a physiologically acceptable alcohol residue or alkanesulphonamido, and the pharmaceutically acceptable salts thereof. The invention also includes processes for the manufacture and use of the acid derivatives as well as pharmaceutical compositions for therapeutic use in one or more of a variety of diseases such as ischaemic heart disease, cerebrovascular disease, asthmatic disease and/or inflammatory disease.

    摘要翻译: 本发明涉及式I的新型药学上有用的1,3-二烷基链烯酸衍生物,其在二恶烷环的第4位含有吡啶基部分,其中第2,4和5位的基团具有顺式相对立体化学,X是 氢,烷氧基或羟基,Y是亚乙烯基,n是1或2,A1是亚烷基,R1是下文定义的各种取代基,R2是羟基,生理上可接受的醇残基或烷基磺酰氨基,及其药学上可接受的盐。 本发明还包括用于制备和使用酸衍生物的方法以及用于治疗用于一种或多种疾病如缺血性心脏病,脑血管疾病,哮喘病和/或炎性疾病的药物组合物。

    2,4-diphenyl-1,3-dioxanes
    9.
    发明授权
    2,4-diphenyl-1,3-dioxanes 失效
    2,4-二苯基-1,3-二恶烷

    公开(公告)号:US4775685A

    公开(公告)日:1988-10-04

    申请号:US861329

    申请日:1986-05-09

    CPC分类号: C07D319/06

    摘要: The invention provides a novel group of 4(Z)-([2,4,5-cis]-2,4-diphenyl-1,3-dioxan-5-yl)hexenoic acids of formula I, wherein X is F, Cl, Br, CF.sub.3, CN, CH.sub.3 O or NO.sub.2 and one of Y and Z is hydrogen or fluoro and the other is hydrogen, and their pharmaceutically acceptable salts; together with their pharmaceutical compositions for use in treating a variety of disease conditions. Also provided are methods for the manufacture of novel compounds. Representative compounds are those in which X is 2-cyano or 2-chloro and Y and Z are both hydrogen.

    摘要翻译: 本发明提供了式I的4(Z) - ([2,4,5-顺式] -2,4-二苯基-1,3-二恶烷-5-基)己烯酸的新型基团,其中X为F, Cl,Br,CF 3,CN,CH 3 O或NO 2,Y和Z中的一个为氢或氟,另一个为氢,及其药学上可接受的盐; 以及用于治疗各种疾病状况的药物组合物。 还提供了制备新化合物的方法。 代表性的化合物是其中X是2-氰基或2-氯并且Y和Z都是氢的化合物。